Clinical Trials Directory

Trials / Unknown

UnknownNCT02074085

Measuring the Incidence of Hospital Readmissions Based on Adverse Drug Events

Measuring the Incidence of Hospital Readmissions, Caused by Adverse Drug Events (ADE) Due to Anticoagulants in Vzw Jessa Hospital (Belgium)

Status
Unknown
Phase
Study type
Observational
Enrollment
450 (estimated)
Sponsor
Hasselt University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

An ADE is defined as harm caused by a drug or the inappropriate use of a drug. Retrospective record reviews in several countries have shown that anticoagulants frequently lead to hospital readmissions. In this study a hospital readmission is defined as an admission to the emergency department of the Jessa hospital. The objective of this study is to determine the incidence of one week and 30-day readmissions caused by (preventable) ADE's due to anticoagulants.

Conditions

Timeline

Start date
2014-03-01
Primary completion
2014-09-01
First posted
2014-02-28
Last updated
2014-02-28

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02074085. Inclusion in this directory is not an endorsement.